| Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? V Ravarotto, G Carraro, E Pagnin, G Bertoldi, F Simioni, G Maiolino, ... PLoS One 13 (9), e0204618, 2018 | 32 | 2018 |
| Oxidative stress and cardiovascular-renal damage in Fabry disease: is there room for a pathophysiological involvement? V Ravarotto, F Simioni, G Carraro, G Bertoldi, E Pagnin, LA Calò Journal of Clinical Medicine 7 (11), 409, 2018 | 27 | 2018 |
| The pivotal role of oxidative stress in the pathophysiology of cardiovascular-renal remodeling in kidney disease V Ravarotto, G Bertoldi, G Innico, L Gobbi, LA Calò Antioxidants 10 (7), 1041, 2021 | 19 | 2021 |
| ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: Support from studies in Bartter’s and Gitelman’s syndromes LA Calò, M Rigato, G Bertoldi QJM: An International Journal of Medicine 113 (6), 440-441, 2020 | 14 | 2020 |
| Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach G Innico, L Gobbi, G Bertoldi, M Rigato, A Basso, L Bonfante, LA Calò Artificial Organs 45 (10), 1202-1207, 2021 | 13 | 2021 |
| Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies V Ravarotto, G Bertoldi, LF Stefanelli, F Nalesso, LA Calò Kidney Research and Clinical Practice 41 (5), 533, 2022 | 12 | 2022 |
| Could nutritional therapy take us further in our approaches to Fabry disease? F Francini-Pesenti, V Ravarotto, G Bertoldi, P Spinella, LA Calò Nutrition 72, 110664, 2020 | 11 | 2020 |
| ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID‐19. G Bertoldi, L Gianesello, LA Calò Alimentary Pharmacology & Therapeutics 52 (3), 2020 | 10 | 2020 |
| Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients LA Calò, G Bertoldi, PA Davis Pharmacological Research 158, 104903, 2020 | 10 | 2020 |
| The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study G Bertoldi, G Carraro, V Ravarotto, VD Vico, PB Anastasio, N Vitturi, ... Frontiers in Nutrition, 1557, 2022 | 9 | 2022 |
| ACE2 and SARS-CoV-2 infection risk: insights from patients with two rare genetic tubulopathies, Gitelman's and Bartter's syndromes LA Calò, M Rigato, L Sgarabotto, L Gianesello, G Bertoldi, V Ravarotto, ... Frontiers in Medicine 8, 647319, 2021 | 9 | 2021 |
| Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes G Bertoldi, V Ravarotto, L Sgarabotto, PA Davis, L Gobbi, LA Calò Journal of Internal Medicine 291 (4), 522, 2022 | 8 | 2022 |
| Rho kinase activity, connexin 40, and atrial fibrillation: mechanistic insights from end-stage renal disease on dialysis patients LA Calò, V Ravarotto, G Bertoldi, E Pagnin, B Rossi, M Rigato, PA Davis, ... Journal of Clinical Medicine 9 (1), 165, 2020 | 8 | 2020 |
| The RAAS goodfellas in cardiovascular system I Caputo, G Bertoldi, G Driussi, M Cacciapuoti, LA Calò Journal of Clinical Medicine 12 (21), 6873, 2023 | 6 | 2023 |
| Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments? G Bertoldi, I Caputo, G Driussi, LF Stefanelli, V Di Vico, G Carraro, ... Journal of Clinical Medicine 12 (5), 2063, 2023 | 5 | 2023 |
| Gitelman’s and Bartter’s Syndromes: From Genetics to the Molecular Basis of Hypertension and More V Ravarotto, G Bertoldi, LF Stefanelli, F Nalesso, LA Calò Kidney and Blood Pressure Research 47 (9), 556-564, 2022 | 5 | 2022 |
| Tracing Angiotensin II's Yin-Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. V Ravarotto, G Bertoldi, M Rigato, E Pagnin, L Gobbi, LA Calò Minerva Medica, 2021 | 5 | 2021 |
| Calcineurin-inhibitor-induced hypomagnesemia in kidney transplant patients: a monocentric comparative study between sucrosomial magnesium and magnesium pidolate supplementation LF Stefanelli, M Alessi, G Bertoldi, V Rossato, V Di Vico, F Nalesso, ... Journal of Clinical Medicine 12 (3), 752, 2023 | 4 | 2023 |
| The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes LF Stefanelli, L Gobbi, V Ravarotto, G Bertoldi, LA Calò Journal of Hypertension 40 (4), 648-649, 2022 | 4 | 2022 |
| Lymphatic vessels and the renin-angiotensin-system G Bertoldi, I Caputo, L Calò, G Rossitto American Journal of Physiology-Heart and Circulatory Physiology 325 (4 …, 2023 | 2 | 2023 |
Lorenzo CalòUniversità di Padova在 aopd.veneto.it 的电子邮件经过验证
